COVID-19 in Cladribine-treated patient with multiple sclerosis.

Haham, Nitsan; Vaknin-Dembinsky, Adi

Haham, Nitsan; Vaknin-Dembinsky, Adi.

Haham N; Department of Neurology and Laboratory of Neuroimmunology, and the Agnes-Ginges Center for Neurogenetics, Hadassah Medical Center, Ein-Karem, Jerusalem 91120, Israel.
Vaknin-Dembinsky A; Department of Neurology and Laboratory of Neuroimmunology, and the Agnes-Ginges Center for Neurogenetics, Hadassah Medical Center, Ein-Karem, Jerusalem 91120, Israel. Electronic address: adembinsky@gmail.com.

J Neuroimmunol ; 359: 577690, 2021 10 15.

Article in English | MEDLINE | ID: covidwho-1347720

ABSTRACT

ABSTRACT

Case report describing a patient infected with COVID-19 after initiation of Cladribine, with a favorable disease course and positive seroconversion.

Subject(s)

COVID-19/immunology; Cladribine/therapeutic use; Immunity, Humoral/drug effects; Immunosuppressive Agents/therapeutic use; Multiple Sclerosis, Relapsing-Remitting/drug therapy; Multiple Sclerosis, Relapsing-Remitting/immunology; COVID-19/diagnostic imaging; Cladribine/pharmacology; Drug Administration Schedule; Humans; Immunity, Humoral/physiology; Immunosuppressive Agents/pharmacology; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting/diagnostic imaging; Treatment Outcome

Keywords

COVID-19; Cladribine; Multiple sclerosis; Neuroimmunology; Seroconversion

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cladribine / Multiple Sclerosis, Relapsing-Remitting / Immunity, Humoral / COVID-19 / Immunosuppressive Agents Type of study: Case report / Prognostic study Limits: Humans / Male / Middle aged Language: English Journal: J Neuroimmunol Year: 2021 Document Type: Article Affiliation country: J.jneuroim.2021.577690

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google